# Nick Williams, Principal > Nick Williams, Principal. The rounds they were named in and the filings that name them, each with its source. Source: https://millionrounds.com/person/nick-williams (Millionrounds; every figure on the page links to its filing or article) London, GB · Partner # Nick Williams Principal at [Medicxi](https://millionrounds.com/fund/medicxi) Profile summary - **Rounds named:** - none observed - **Filings:** 20 with regulators What this record rests on - **Named in rounds** No round names them yet - ✓ **On filings** 20 filings with a regulator - ✓ **Linked to a firm** At Medicxi - **Claimed** Not claimed yet Titles come from filings their firm signed. [Correct or remove](https://millionrounds.com/corrections?person=nick-williams)[Is this you? Claim it](https://millionrounds.com/claim?person=nick-williams) ## The firm [**Medicxi** VC firm · GB **2** cheques in 12 months **10** all time **1** led deploying](https://millionrounds.com/fund/medicxi) ## Companies they are listed as backing Portfolio - [Alderaan Biotechnology](https://millionrounds.com/startup/alderaan-biotechnology) - [ApcinteX](https://millionrounds.com/company/apcintex) - [Aura Biosciences](https://millionrounds.com/company/aura-biosciences) - [Breakpoint Therapeutics](https://millionrounds.com/startup/breakpoint-therapeutics) - [Capella BioScience](https://millionrounds.com/startup/capella-bioscience) - [Checkmate Pharmaceuticals](https://millionrounds.com/company/checkmate-pharmaceuticals) - [Critical Pressure](https://millionrounds.com/startup/critical-pressure) - [Diasome Pharmaceuticals](https://millionrounds.com/startup/diasome-pharmaceuticals) - [Divide and Conquer](https://millionrounds.com/company/divide-and-conquer) - [Gadeta](https://millionrounds.com/startup/gadeta) - [Impact Biomedicines](https://millionrounds.com/company/impact-biomedicines) - [Kymo Therapeutics](https://millionrounds.com/startup/kymo-therapeutics-2) - [Mavalon Therapeutics](https://millionrounds.com/startup/mavalon-therapeutics) - [Morphogen-IX](https://millionrounds.com/startup/morphogen-ix) - [Orexia](https://millionrounds.com/startup/orexia) - [Palladio Biosciences](https://millionrounds.com/startup/palladio-biosciences) - [Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals) - [Stealthyx Therapeutics](https://millionrounds.com/startup/stealthyx-therapeutics-ltd) - [SuperX](https://millionrounds.com/company/superx) - [Sydnexis](https://millionrounds.com/startup/sydnexis) - [Synthorx](https://millionrounds.com/company/synthorx) - [Vaxcyte](https://millionrounds.com/startup/vaxcyte) - [Xenikos](https://millionrounds.com/company/xenikos) - [Yukin Therapeutics](https://millionrounds.com/startup/yukin-therapeutics) - [Z Factor](https://millionrounds.com/company/z-factor) - Inexia - Janpix ## Where they are named on record Filings - SEC Form D · Hedge fund **BLUEBAY EVENT DRIVEN CREDIT FUND LP** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY EVENT DRIVEN CREDIT (MASTER) FUND LTD** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY GLOBAL CREDIT ALPHA LONG SHORT FUND LTD** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY GLOBAL SOVEREIGN OPPORTUNITIES FUND LP** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY EVENT DRIVEN CREDIT FUND LTD.** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY GLOBAL CREDIT ALPHA LONG SHORT FUND LP** Director since 2024 - SEC Form D · Hedge fund **BLUEBAY EMERGING MARKET CREDIT ALPHA FUND LTD.** Director since 2024 - SEC Form D · Hedge fund **GLOBAL SOVEREIGN OPPORTUNITIES FUND LP** Director since 2023 - SEC Form D · Hedge fund **[EMERGING](https://millionrounds.com/fund/emerging)** Director since 2020 - SEC Form D · Hedge fund **GLOBAL CREDIT ALPHA LONG SHORT FUND LTD** Director on 8 filings · since 2018 - SEC Form D · Hedge fund **GLOBAL CREDIT ALPHA LONG SHORT FUND LP** Director on 4 filings · since 2018 - SEC Form D · Hedge fund **GLOBAL FUNDS SPC - INVESTMENT GRADE ABSOLUTE RETURN BOND SP** Director since 2017 - SEC Form D · Hedge fund **CREDIT ALPHA LONG SHORT (MASTER) FUND LTD** Director since 2017 - SEC Form D · Hedge fund **CREDIT ALPHA LONG SHORT FUND LTD** Director since 2017 - SEC Form D · Hedge fund **GLOBAL FUNDS SPC - EMERGING MARKET SELECT BOND SP** Director on 9 filings · since 2017 - SEC Form D · Hedge fund **EVENT DRIVEN CREDIT FUND LTD** Director on 8 filings · since 2017 - SEC Form D · Hedge fund **EMERGING MARKET CREDIT ALPHA (MASTER) FUND LTD** Director on 5 filings · since 2017 - SEC Form D · Hedge fund **EMERGING MARKET CREDIT ALPHA FUND LTD** Director on 7 filings · since 2017 - SEC Form D · Hedge fund **EVENT DRIVEN CREDIT (MASTER) FUND LTD** Director on 5 filings · since 2017 - SEC Form D · Hedge fund **EMERGING MARKET BLENDED BOND SP OF THE BLUEBAY GLOBAL FUNDS SPC** Director since 2017 Each row is a document a firm filed with a regulator: somebody signed it, and it carries a date. ## Also at Medicxi - [**Kevin Johnson** General Partner *1 round*](https://millionrounds.com/person/kevin-johnson-3) - [**David Grainger** Chairman of Development, Rivus Pharmaceuticals *0 rounds*](https://millionrounds.com/person/david-grainger) - [**Francesco Rubertis** Shareholder *0 rounds*](https://millionrounds.com/person/francesco-rubertis) - [**Giovanni Mariggi** Shareholder *0 rounds*](https://millionrounds.com/person/giovanni-mariggi) - [**Giovanni Pericolini** Partner and CFO *0 rounds*](https://millionrounds.com/person/giovanni-pericolini) - [**Giuseppe Zocco** Co-Founder and Partner *0 rounds*](https://millionrounds.com/person/giuseppe-zocco) - [**Jon Edwards** Partner *0 rounds*](https://millionrounds.com/person/jon-edwards) - [**Mich Ele Ollier** Partner *0 rounds*](https://millionrounds.com/person/mich-ele-ollier) ## Find people like Nick Filter every partner and angel by firm, kind, market and whether we watched them invest. Free with an account. Search people[How we know what we know](https://millionrounds.com/methodology)